Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2018 Jun 18;102(2):287–295. doi: 10.1016/j.ijrobp.2018.06.008

Table 3.

Number of patients with an adverse event by system organ class, term, and grade

System organ class Acute
Late
5 fractions
(n = 119)
12 fractions
(n = 121)
5 fractions
(n = 119)
12 fractions
(n = 121)
Grade
Grade
Grade
Grade
3 4 5 3 4 5 3 4 5 3 4 5
Gastrointestinal disorders 1 0 0 2 0 0 1 0 0 1 0 0
 Colonic fistula 0 0 0 0 0 0 0 0 0 1 0 0
 Diarrhea 1 0 0 0 0 0 0 0 0 0 0 0
 Proctitis 0 0 0 2 0 0 1 0 0 1 0 0
Renal and urinary disorders 1 0 0 0 0 0 1 0 0 1 0 0
 Cystitis noninfective 0 0 0 0 0 0 1 0 0 0 0 0
 Renal and urinary disorders, other 0 0 0 0 0 0 1 0 0 0 0 0
 Urinary incontinence 0 0 0 0 0 0 1 0 0 0 0 0
 Urinary retention 1 0 0 0 0 0 0 0 0 1 0 0
 Urinary tract obstruction 0 0 0 0 0 0 1 0 0 0 0 0

Includes adverse events for which relationship to protocol treatment is missing. Adverse events were graded with Common Terminology Criteria for Adverse Events version 4. Gastrointestinal/genitourinary grade 3+ treatment-related toxicity definitely, probably, or possibly related to protocol treatment.